Dianne Webster

ORCID: 0000-0003-4518-0626
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metabolism and Genetic Disorders
  • Neonatal Health and Biochemistry
  • Biochemical and Molecular Research
  • Cytomegalovirus and herpesvirus research
  • Thyroid Disorders and Treatments
  • Sexual Differentiation and Disorders
  • Neonatal Respiratory Health Research
  • Adenosine and Purinergic Signaling
  • Genomics and Rare Diseases
  • Mitochondrial Function and Pathology
  • Folate and B Vitamins Research
  • Blood groups and transfusion
  • Diet and metabolism studies
  • Prenatal Screening and Diagnostics
  • Cystic Fibrosis Research Advances
  • Neuroscience of respiration and sleep
  • Blood disorders and treatments
  • Hormonal and reproductive studies
  • Immunodeficiency and Autoimmune Disorders
  • Congenital heart defects research
  • HIV/AIDS drug development and treatment
  • Porphyrin Metabolism and Disorders
  • Congenital Heart Disease Studies
  • Ethics in Clinical Research
  • Gout, Hyperuricemia, Uric Acid

University of Auckland
1984-2025

Office of Naval Research
2024

Auckland City Hospital
2012-2024

Groote Schuur Hospital
2024

Auckland District Health Board
2010-2023

Newfoundland and Labrador Centre for Applied Health Research
2018

Ministry of Health
2014

Hospital Clínico Universitario de Valladolid
2010

Memorial Medical Center
2009

Greenlane Clinical Centre
1991-2008

Gregg Marquardt Robert J. Currier David McHugh Dimitar Gavrilov Mark J Magera and 95 more Dietrich Matern Devin Oglesbee Kimiyo Raymond Piero Rinaldo Emily H. Smith Silvia Tortorelli Coleman Turgeon Fred Lorey Bridget Wilcken Veronica Wiley Lawrence Greed Barry Lewis François Boemer Roland Schoos Sandrine Marie Marie‐Françoise Vincent Yuri Cleverthon Sica Mouseline Torquado Domingos Khalid Al‐Thihli Graham Sinclair Osama Y. Al-Dirbashi Pranesh Chakraborty Mark Dymerski Cory Porter Adrienne Manning Margretta R. Seashore Jonessy Quesada Alejandra Reuben Petr Chrastina Petr Horník Iman Mandour Sahar Sharaf Olaf A. Bodamer Bonifacio Dy Jasmin Torres Roberto Zori David Cheillan Christine Vianey‐Saban David Ludvigson Adrya Stembridge Jim Bonham Melanie Downing Yannis Dotsikas Yannis L. Loukas Vagelis Papakonstantinou Georgios S.A. Zacharioudakis Ákos Baráth Eszter Karg Leifur Franzson Jón J. Jónsson Nancy N. Breen Barbara G. Lesko Stanton L. Berberich Kimberley Turner Margherita Ruoppolo Emanuela Scolamiero I. Antonozzi Claudia Carducci Ubaldo Caruso Michela Cassanello Giancarlo la Marca Elisabetta Pasquini Iole Maria Di Gangi Giuseppe Giordano Marta Camilot Francesca Teofoli Shawn Manos Colleen K. Peterson Stephanie K. Mayfield Gibson Darrin W. Sevier Soo‐Youn Lee Hyung‐Doo Park Issam Khneisser Phaidra Browning Fizza Gulamali-Majid Michael S. Watson Roger B. Eaton Inderneel Sahai Consuelo Ruiz Rosário Torres Mary Seeterlin Eleanor Stanley Amy Hietala Mark McCann Carlene Campbell Patrick V. Hopkins Monique G. de Sain-van der Velden Bert Elvers Mark A. Morrissey Sherlykutty Sunny Detlef Knoll Dianne Webster Dianne M. Frazier Julie McClure David E. Sesser

10.1038/gim.2012.2 article EN publisher-specific-oa Genetics in Medicine 2012-07-01

Recent reports suggest that the incidence of congenital hypothyroidism (CHT) is increasing in some countries. The etiology this change unclear, and it may relate to changes screening thresholds. We aimed determine whether CHT New Zealand has changed ethnic-specific rates subtypes have also changed.The neonatal TSH-based program prospectively identified cases using same assay thresholds since 1993. Thyroid scintiscans are routinely recommended. retrospectively all requiring levothyroxine...

10.1210/jc.2012-1562 article EN The Journal of Clinical Endocrinology & Metabolism 2012-06-22

We investigated the feasibility and diagnostic utility of genotyping 9 CYP21 mutations, linked chromosome 6p markers, a dimorphic X-Y marker from neonatal screening samples. Blood-impregnated filter papers (Guthrie cards) 603 randomly chosen New Zealand neonates were genotyped blind to 17-hydroxyprogesterone (17-OHP) levels. Another 50 samples Swiss North American infants with correlative hormonal data also genotyped. DNA was extracted, gene-specific PCR performed. products subjected ligase...

10.1210/jcem.84.3.5550 article EN The Journal of Clinical Endocrinology & Metabolism 1999-03-01

Despite newborn screening and early levothyroxine replacement, there are continued reports of mild neurocognitive impairment in children with congenital hypothyroidism (CHT). In Auckland, New Zealand, cases identified by a neonatal program rapid institution high-dose replacement (10–15 μg/kg·d), producing prompt normalization thyroid function. Subsequently, frequent monitoring dose alterations performed for 2 years. We aimed to assess whether the Auckland treatment strategy prevents...

10.1210/jc.2013-1903 article EN The Journal of Clinical Endocrinology & Metabolism 2013-07-17

The objective of the study was to evaluate efficacy national newborn screening for severe congenital adrenal hyperplasia (CAH) in New Zealand over past 20 years.Newborn CAH is performed through estimation 17-hydroxyprogesterone by a Delfia immunoassay. cases diagnosed period from 1994 2013 were identified Newborn Metabolic Screening Programme records.Between and 2013, 44 neonates (28 females, 16 males) with CAH, giving an incidence 1:26 727. Almost half (n = 21) newborns detected solely via...

10.1210/jc.2014-3168 article EN The Journal of Clinical Endocrinology & Metabolism 2014-12-12

<h3>Background</h3> Variants of <i>SCN5A</i>, encoding cardiac sodium channel, have been linked to the development dilated cardiomyopathy (DCM). We aimed explore novel <i>SCN5A</i> variants in patients with idiopathic DCM (iDCM) and identify distribute characteristics pathological mechanisms as well clinical phenotypes associated iDCM. <h3>Methods</h3> exons sequencing was performed inpatients iDCM (n=90) two control cohorts (arrhythmias group, n=90, healthy n=195). Clinical were compared...

10.1136/bmj.4.5832.117 article EN BMJ 1972-10-14

Worldwide, comprehensive newborn screening (NBS) now includes a clinical examination at birth, hearing screening, pulse oximetry measurement for congenital heart defects, and biochemical to identify disorders early in life, preventing irreversible damage, mortality enhancing overall health outcomes. This article provides overview of NBS South Africa, outlining the history, current status, future plans expansion. In is fragmented, with some investigations included neonatal assessments....

10.20517/rdodj.2023.49 article EN Rare Disease and Orphan Drugs Journal 2024-02-29

The International Society for Neonatal Screening (ISNS) has supported the standardization of measurement key biochemical markers neonatal screening diseases: thyroid-stimulating hormone (TSH) congenital hypothyroidism, phenylalanine (PHE) phenylketonuria, and 17α-hydroxyprogesterone (17OHP) adrenal hyperplasia. These diseases are commonly a part panels worldwide. ISNS provides series secondary reference materials to manufacturers reagents assist in production calibration kits. This technical...

10.3390/ijns11010013 article EN cc-by International Journal of Neonatal Screening 2025-02-09

aims: Severe B12 deficiency is harmful to infants. This study describes the recent detection and treatment rates of antenatal infant in Auckland–Northland region. method: Regional laboratory data on serum levels were analysed. deficient infants pregnant women identified paired with their corresponding mother or infant, followed by a review electronic health records. results: Testing incidence was low (5 per 1,000 year). Among 529 tested over 5 years, 6% exhibited (&lt;148pmol/L). Antenatal...

10.26635/6965.6615 article EN New Zealand medical journal 2025-02-27

Summary Objective To determine the effectiveness of a novel therapeutic paradigm to treat congenital hypothyroidism (CH) incorporating variable initial doses L‐T4 based on underlying aetiology and frequent monitoring, up 2 years age. Design Retrospective cohort study. Patients Infants with primary CH diagnosed by newborn screening. Measurements Treatment suspension initiated at 10, 12 15 µg/kg/day for dyshormonogenesis, ectopia athyreosis, respectively. Serum TSH free T4 (FT4) levels...

10.1111/j.1365-2265.2008.03172.x article EN Clinical Endocrinology 2008-06-17

Webster, D. R. M.D. Ph.D.; Henrikson, H. Winter Currie, J. Author Information

10.1097/00000658-195010000-00014 article EN Annals of Surgery 1950-10-01
Coming Soon ...